Glassman Wealth Services’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13
| Closed | -$62 | – | 1264 |
|
|
2023
Q4 | $62 | Hold |
13
| – | – | ﹤0.01% | 1944 |
|
|
2023
Q3 | $94 | Hold |
13
| – | – | ﹤0.01% | 1972 |
|
|
2023
Q2 | $97 | Hold |
13
| – | – | ﹤0.01% | 1886 |
|
|
2023
Q1 | $90 | Hold |
13
| – | – | ﹤0.01% | 1878 |
|
|
2022
Q4 | $134 | Sell |
13
-5
| -28% | -$88 | ﹤0.01% | 1857 |
|
|
2022
Q3 | $0 | Sell |
18
-42
| -70% | -$1.82K | ﹤0.01% | 1886 |
|
|
2022
Q2 | $3K | Buy |
60
+46
| +329% | +$2.38K | ﹤0.01% | 1154 |
|
|
2022
Q1 | $1K | Buy |
14
+8
| +133% | +$713 | ﹤0.01% | 1463 |
|
|
2021
Q4 | $1K | Sell |
6
-8
| -57% | -$1.38K | ﹤0.01% | 1439 |
|
|
2021
Q3 | $3K | Buy |
14
+4
| +40% | +$882 | ﹤0.01% | 1084 |
|
|
2021
Q2 | $2K | Hold |
10
| – | – | ﹤0.01% | 1160 |
|
|
2021
Q1 | $2K | Sell |
10
-140
| -93% | -$27.9K | ﹤0.01% | 1115 |
|
|
2020
Q4 | $17K | Hold |
150
| – | – | ﹤0.01% | 575 |
|
|
2020
Q3 | $16K | Sell |
150
-56
| -27% | -$6.82K | ﹤0.01% | 490 |
|
|
2020
Q2 | $17K | Buy |
+206
| New | +$7.88K | 0.01% | 408 |
|
|
2019
Q4 | – | Sell |
-50
| Closed | – | – | 1384 |
|
|
2019
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 1274 |
|
|
2019
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 1274 |
|
|
2019
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 856 |
|
|
2018
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 566 |
|
|
2018
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 606 |
|
|
2018
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 695 |
|
|
2018
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 548 |
|
|
2017
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 600 |
|
|
2017
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 490 |
|
|
2017
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 486 |
|
|
2017
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 518 |
|
|
2016
Q4 | $1K | Hold |
50
| – | – | ﹤0.01% | 572 |
|
|
2016
Q3 | $2K | Hold |
50
| – | – | ﹤0.01% | 407 |
|
|
2016
Q2 | $7K | Hold |
50
| – | – | 0.01% | 362 |
|
|
2016
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 375 |
|
|
2015
Q4 | $8K | Hold |
50
| – | – | 0.01% | 338 |
|
|
2015
Q3 | $7K | Hold |
50
| – | – | 0.01% | 336 |
|
|
2015
Q2 | $11K | Hold |
50
| – | – | 0.01% | 312 |
|
|
2015
Q1 | $8K | Sell |
50
-100
| -67% | -$16.2K | 0.01% | 357 |
|
|
2014
Q4 | $18K | Buy |
+150
| New | +$15.7K | 0.01% | 263 |
|
Other funds holding NVAX
SCM
Glassman Wealth Services's NVAX Position: Q1 2024 in Review
Glassman Wealth Services sold out of Novavax (NVAX) in Q1 2024, closing a stake of 13 shares — an estimated $62 sold.
Glassman Wealth Services first reported a position in NVAX in Q4 2014 and held it in 35 quarters. The position peaked at $18K in Q4 2014. 201 funds tracked by Wall St. Rank hold NVAX as of Q1 2024.
- Glassman Wealth Services reported no remaining Novavax position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 13 Novavax shares in Q1 2024, an estimated $62.
- Glassman Wealth Services first reported a position in Novavax in Q4 2014 and held it in 35 quarters.
- Glassman Wealth Services's Novavax position peaked at $18K in Q4 2014.
- 201 funds tracked by Wall St. Rank held Novavax as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.